Novel M3 muscarinic acetylcholine receptor antagonists

Details for Australian Patent Application No. 2004296207 (hide)

Owner Glaxo Group Limited

Inventors Palovich, Michael R.; Fu, Wei; BuschPetersen, Jakob; Jin, Jian

Agent Davies Collison Cave

Pub. Number AU-A-2004296207

PCT Pub. Number WO2005/055940

Priority 60/526,824 03.12.03 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

International Classifications

C07D 211/68 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 211/08 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/055940 Priority application(s): WO2005/055940

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296208-Novel M3 muscarinic acetylcholine receptor antagonists

2004296206-Treatment and preventions of asthma